Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Abstract With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billion in the US...

Full description

Bibliographic Details
Main Authors: Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit Mollenhauer, Peter Lansbury, Tiago F. Outeiro
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-021-00203-9

Internet

https://doi.org/10.1038/s41531-021-00203-9

Similar Items